ARQT R&D to Revenue
Arcutis Biotherapeutics Inc · R&D to Revenue
ARQT R&D to Revenue
Latest reported15.67%period ending
ARQT Quarterly R&D/Revenue (0.00% → 15.67%)
Latest values, visible window
High-resolution chart · PNG
ARQT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 15.6745% | |
| 29.0584% | |
| 15.7919% | |
| 19.7583% | |
| 23.8675% | |
| 26.6425% | |
| 20.2915% | |
| 43.5728% | |
| 62.5381% | |
| 46.6844% | |
| 175.7726% | |
| 68.8446% | |
| 485.9152% | |
| 1,270.9457% | |
| 1,144.1067% | |
| 9,618.069% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |